Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Intra-Cellular Therapies (ITCI) stocks in Canada
Learn how to easily invest in Intra-Cellular Therapies stocks.
Intra-Cellular Therapies is a drug manufacturers-specialty & generic business based in the US. Intra-Cellular Therapies stocks (ITCI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $40.34 – a decrease of 9.75% over the previous week. Intra-Cellular Therapies employs 383 staff and has a trailing 12-month revenue of around $70.6 million.
How to buy shares in Intra-Cellular Therapies
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ITCI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Intra-Cellular Therapies?
- Has coronavirus impacted Intra-Cellular Therapies shares?
- Intra-Cellular Therapies shares summary
- Compare share dealing platforms
- Is Intra-Cellular Therapies stock a buy or sell?
- Intra-Cellular Therapies performance over time
- Intra-Cellular Therapies's financials
- How volatile are Intra-Cellular Therapies shares?
- Does Intra-Cellular Therapies pay a dividend?
- Other common questions
Intra-Cellular Therapies stock price (NASDAQ:ITCI)Use our graph to track the performance of ITCI stocks over time.
Intra-Cellular Therapies shares at a glance
|Latest market close||$38.87|
|52-week range||$28.40 - $55.20|
|50-day moving average||$42.71|
|200-day moving average||$38.22|
|Wall St. target price||$60.89|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.20|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Intra-Cellular Therapies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Intra-Cellular Therapies price performance over time
|1 week (2022-01-12)||-2.14%|
|1 month (2021-12-17)||N/A|
|3 months (2021-10-21)||-9.37%|
|6 months (2021-07-21)||3.54%|
|1 year (2021-01-21)||18.92%|
|2 years (2020-01-21)||52.85%|
|3 years (2019-01-18)||209.72%|
|5 years (2017-01-20)||186.23%|
Intra-Cellular Therapies financials
|Revenue TTM||$70.6 million|
|Gross profit TTM||$-44,864,187|
|Return on assets TTM||-24.56%|
|Return on equity TTM||-43.32%|
|Market capitalisation||$4 billion|
TTM: trailing 12 months
Intra-Cellular Therapies share dividends
We're not expecting Intra-Cellular Therapies to pay a dividend over the next 12 months.
Intra-Cellular Therapies share price volatility
Over the last 12 months, Intra-Cellular Therapies's shares have ranged in value from as little as $28.4 up to $55.195. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Intra-Cellular Therapies's is 1.1429. This would suggest that Intra-Cellular Therapies's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Intra-Cellular Therapies overview
Intra-Cellular Therapies, Inc. , a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also developing lumateperone, which is in Phase 3 clinical trials for the treatment of bipolar depression, as well as to treat autism spectrum disorder, and sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing ITI-002 that inhibits the enzyme phosphodiesterase type 1; ITI-214 for the treatment of Parkinson's disease and heart failure; ITI-1284 for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333, for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.
Stocks similar to Intra-Cellular Therapies
Intra-Cellular Therapies in the news
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Intra-Cellular Therapies (ITCI) Investor Presentation - Slideshow
Frequently asked questions
More guides on Finder
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.